New diabetes drug aims to make insulin work better
NCT ID NCT07465224
Summary
This study is testing whether a single dose of an investigational drug called ALN-4324 can improve how the body responds to insulin in people with type 2 diabetes. It will involve 40 adult participants who have type 2 diabetes and are already taking a stable dose of metformin. Researchers will measure changes in insulin sensitivity and blood sugar control to see if the treatment is effective and safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Trial Site
RECRUITINGChula Vista, California, 91911, United States
Conditions
Explore the condition pages connected to this study.